rs1057519897
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs869320694
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121913459
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
rs121913461
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
rs121913459
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia.
|
22772060 |
2013 |
rs1057519721
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Sorafenib treatment of FLT3-ITD(+) acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation.
|
22368270 |
2012 |
rs1057519721
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia.
|
22955920 |
2012 |
rs1057519722
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia.
|
22955920 |
2012 |
rs1057519722
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Sorafenib treatment of FLT3-ITD(+) acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation.
|
22368270 |
2012 |
rs1057519723
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Sorafenib treatment of FLT3-ITD(+) acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation.
|
22368270 |
2012 |
rs1057519723
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Sorafenib treatment of FLT3-ITD(+) acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation.
|
22368270 |
2012 |
rs1057519723
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia.
|
22955920 |
2012 |
rs1057519723
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia.
|
22955920 |
2012 |
rs1057519743
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study.
|
22368272 |
2012 |
rs1057519759
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.
|
22897847 |
2012 |
rs1057519759
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia.
|
22955920 |
2012 |
rs151047872
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia.
|
22955920 |
2012 |
rs1057519753
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.
|
21680795 |
2011 |
rs1057519743
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemia.
|
19907440 |
2010 |
rs1057519743
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia.
|
20018760 |
2010 |
rs1057519743
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group.
|
19965641 |
2010 |
rs869312953
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
ALL-associated JAK1 mutations confer hypersensitivity to the antiproliferative effect of type I interferon.
|
20167706 |
2010 |
rs1057519721
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
JAK mutations in high-risk childhood acute lymphoblastic leukemia.
|
19470474 |
2009 |
rs1057519722
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
JAK mutations in high-risk childhood acute lymphoblastic leukemia.
|
19470474 |
2009 |
rs1057519723
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
JAK mutations in high-risk childhood acute lymphoblastic leukemia.
|
19470474 |
2009 |